Crossject

Crossject SA is developing and will soon launch a series of medications for emergency situations (epilepsy, drug overdose, anaphylactic shock, severe migraines, and asthma attacks). With its patented needle-free self-injection system, Crossject aims to become the global leader in self-administered emergency drugs.